Emoleculare Vets Pharma Llp - Company Profile

It is a home appliances limited liability partnership based in Agartala, Tripura, India, established in 2021.
2021 Agartala, Tripura, India Active
Last Updated:
Access Report
About Emoleculare Vets Pharma Llp

Emoleculare Vets Pharma Llp, a active limited liability partnership, was established on 24 February 2021 in Agartala, Tripura, India. Engaging in repair of personal and household goods within the home appliances sector, it holds LLPIN: AAW-0359. Registered under ROC Roc Guwahati. It has total obligation of contribution of ₹3.00 K .

Its leadership includes Ashis Kanti Pal (Designated Partner), Diptanu Saha (Designated Partner), Subankar Debnath (Designated Partner). Its latest date of accounts and solvency statement 31 March 2024. It is based at C/O Dipti Kar Roy W/O Manindra Ch Roy, Khejurbagan, Agartala, Tripura, 799001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAW-0359

  • Incorporation Date

    24 February 2021

  • Total Obligation of Contribution

    ₹3.00 K

  • ROC Code

    Roc Guwahati

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 3.00 K
  • Company Age 5 Year, 8 Days
  • Last Filing with ROC 31 Mar 2024
Company report

Emoleculare Vets Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Emoleculare Vets Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Emoleculare Vets Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Ashis Kanti Pal Designated Partner 24 Feb 2021 Current
Diptanu Saha Designated Partner 24 Feb 2021 Current
Subankar Debnath Designated Partner 24 Feb 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Emoleculare Vets Pharma Llp.

Enhance accessibility to Emoleculare Vets Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Emoleculare Vets Pharma Llp revenue growth over time
Emoleculare Vets Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Emoleculare Vets Pharma Llp?

Unlock access to Emoleculare Vets Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Emoleculare Vets Pharma Llp?

Unlock and access historical data on people associated with Emoleculare Vets Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Emoleculare Vets Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emoleculare Vets Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Emoleculare Vets Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Emoleculare Vets Pharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Emoleculare Vets Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was completed.

  • Director Appointment

    The activity Ashis Kanti Pal was appointed as a Designated Partner was appointed as a Designated Partner on 24 Feb 2021 & has been associated with this company since 5 years 8 days . was completed.

  • Director Appointment

    Diptanu Saha was appointed as a Designated Partner was appointed as a Designated Partner on 24 Feb 2021 & has been associated with this company since 5 years 8 days . was recorded as a recent event.

  • Director Appointment

    Progress on Subankar Debnath was appointed as a Designated Partner was appointed as a Designated Partner on 24 Feb 2021 & has been associated with this company since 5 years 8 days . was documented.

  • LLP Incorporation

    Progress on Emoleculare Vets Pharma Llp was registered on 24 Feb 2021 with Roc Guwahati & aged 5 years 8 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Emoleculare Vets Pharma Llp?

The LLPIN of Emoleculare Vets Pharma Llp is AAW-0359.

Where is Emoleculare Vets Pharma Llp headquartered?

Emoleculare Vets Pharma Llp is headquartered at C/O Dipti Kar Roy W/O Manindra Ch Roy, Khejurbagan, Agartala, Tripura, 799001.

When was Emoleculare Vets Pharma Llp incorporated?

Emoleculare Vets Pharma Llp was incorporated on 24 February 2021.

Who are the current directors of Emoleculare Vets Pharma Llp?

The current directors of Emoleculare Vets Pharma Llp are

What is the primary industry of Emoleculare Vets Pharma Llp?

The primary industry of Emoleculare Vets Pharma Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available